Search for: "Deas v. Deas"
Results 1 - 20
of 797
Sort by Relevance
|
Sort by Date
2 Jun 2025, 7:00 am
If any such paraphernalia business is interested in challenging this policy, I would encourage them to do so – particularly in light of the Supreme Court’s decision in Loper Bright Enterprises v. [read post]
19 May 2025, 6:14 pm
Patients who repeatedly seek early fills of schedule II prescriptions or refills of schedule III-V prescriptions earlier than the date the drug would have run out if taken according to the prescriber’s instructions. ⁋⁋ 81, 89, 251. [read post]
16 May 2025, 6:42 am
Tovar v. [read post]
“This Judge is a Hero”: Democratic Politicians and Judges Praise Judge Dugan and Call for Resistance
29 Apr 2025, 3:25 am
As Justice Louis Brandeis stated in Olmstead v. [read post]
27 Apr 2025, 9:02 pm
United States and Printz v. [read post]
11 Apr 2025, 6:25 am
Greenspan v. [read post]
11 Apr 2025, 2:05 am
In MMJ BioPharma Cultivation, Inc. v. [read post]
2 Apr 2025, 11:37 am
Farris v. [read post]
21 Mar 2025, 11:02 am
DEA, where the court upheld the DEA’s denial of psilocybin use under the Controlled Substances Act. [read post]
11 Mar 2025, 9:08 am
Kendrick v. [read post]
8 Mar 2025, 5:35 pm
In United States v. [read post]
7 Mar 2025, 12:30 pm
So, we're happy to say that on April 29th the Supreme Court will hear Martin v. [read post]
6 Mar 2025, 3:11 am
” Barlow-Ahsan v. [read post]
3 Mar 2025, 7:41 pm
Puzey v. [read post]
14 Feb 2025, 12:30 pm
And in a recent case—United States v. [read post]
11 Feb 2025, 10:53 am
This schedule of drugs works much like the federal Drug Enforcement Agency’s (DEA) classification system. [read post]
10 Feb 2025, 7:27 am
DEA, a three-judge panel applied the Decker Coal doctrine in a short opinion that affirmed the DEA’s order against Dr. [read post]
3 Feb 2025, 7:30 pm
During the COVID-19 PHE, the Ryan Haight Act’s in-person medical evaluation requirement was lifted under the fourth exception, thereby allowing DEA-registered practitioners to prescribe Schedule II-V controlled substances during audio-video telemedicine encounters and certain audio-only visits without requiring a prior in-person medical evaluation. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
